Selective serotonin reuptake inhibitors: measurement of effect on platelet function

Translational Research

Volumn 151, Issue 3, 2008, Pages 168-172

  McCloskey, Donna Jo ^a   Postolache, Teodor T ^b   Vittone, Bernard J ^c   Nghiem, Khanh L ^a   Monsale, Jude L ^a   Wesley, Robert A ^a   Rick, Margaret E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c National Center for the Treatment of Phobias   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; AMFEBUTAMONE; ARACHIDONIC ACID; CITALOPRAM; COLLAGEN; FLUOXETINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; FEMALE; FUNCTION TEST; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION;

EID: 38949186806     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.10.004     Document Type: Article

References (20)

1. Masand P.S., and Gupta S. Selective serotonin-reuptake inhibitors: an update. Harv Rev Psychiatry 7 (1999) 69-84
2. Moynihan R. Drug spending in North America rose by 11% in 2003. BMJ 328 (2004) 727
3. Goldberg R.J. Selective serotonin reuptake inhibitors: infrequent medical adverse effects. Arch Fam Med 7 (1998) 78-84
4. de Abajo F.J., Rodriguez L.A.G., and Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319 (1999) 1106-1109
5. Dalton S.O., Johansen C., Mellemkjaer L., Norgard B., Sorensen H.T., and Olsen J.H. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163 (2003) 59-64
6. Dalton S.O., Sørensen H.T., and Johansen C. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing. CNS Drugs 20 (2006) 143-151
7. Halperin D., and Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 9 (2007) 47-59
8. de Abajo F.J., Montero D., Rodriguez L.A.G., and Madurga M. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol 98 (2006) 304-310
9. Helin-Salmivaara A., Huttunen T., Gronroos J.M., Klaukka T., and Huupponen R. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case control study in the general population. Eur J Clin Pharmacol 63 (2007) 403-408
10. Meijer W.E., Heerdink E.R., Nolen W.A., Herings R.M.C., Leufkens H.G.M., and Egberts A.C.G. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 164 (2004) 2367-2370
11. Movig K.L.L., Janssen M.W.H.E., de Waal Malefijt J., Kabel P.J., Leufkens H.G.M., and Egberts A.C.G. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 163 (2003) 2354-2358
12. Verbeuren T.J. Synthesis, storage, release and metabolism of 5-hydroxytryptamine in peripheral tissues. In: Fozard J.R. (Ed). The peripheral actions of 5-hydroxytryptamine (1989), Oxford University Press, New York, NY 1-25
13. De Clerck F. The role of serotonin in thrombogenesis. Clin Physiol Biochem 8 suppl 3 (1990) 40-49
14. Serebruany V.L., Glassman A.H., Malinin A.I., Atar D., Sane D.C., Oshrine B.R., et al. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail 5 (2003) 517-521
15. Mammen E.F., Comp P.C., Gosselin R., et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 24 (1998) 195-202
16. Harrison P., Robinson M., Liesner R., et al. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin Lab Haematol 24 (2002) 225-232
17. Kotzailias N., Andonovski T., Dukic A., Serebruany V.L., and Jilma B. Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial. J Clin Pharmacol 46 (2006) 468-475
18. Hergovich N., Aigner M., Eichler H.G., Entlicher J., Drucker C., and Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 68 (2000) 435-442
19. Musselman D.L., Tomer A., Manatunga A.K., et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 153 (1996) 1313-1317
20. Remaley A.T., Kennedy J.M., and Laposata M. Evaluation of the clinical utility of platelet aggregation studies. Am J Hemat 31 (1989) 188-193